At a glance
- Originator Nonindustrial source
- Class Antihypertensives; Piperazines; Tetrahydronaphthalenes
- Mechanism of Action Alpha 1 adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 16 Jul 1998 No-Development-Reported for Hypertension in Spain (Unknown route)
- 20 Oct 1995 New profile
- 20 Oct 1995 Preclinical development for Hypertension in Spain (Unknown route)